معرفی
Andrew Dillin is a Professor of Immunology and Molecular Medicine and the Howard Hughes Medical Institute Investigator at the University of California, Berkeley. He holds the Thomas and Stacey Siebel Distinguished Chair in Stem Cell Biology. His research focuses on understanding the molecular mechanisms of aging, proteostasis, and mitochondrial dysfunction, with a particular emphasis on how cellular stress responses and inter-organ communication influence health span and longevity.
Key projects in his lab include studying mitochondrial and ER stress signaling, the role of HSF-1 in cytoplasmic stress responses, and how nutrient availability and germline signaling impact aging. His work integrates model organisms (C. elegans, mice, stem cells) with advanced techniques like ribosome profiling and CRISPR screens to dissect aging pathways.
Notable achievements include discoveries regarding cell non-autonomous mitochondrial stress signaling, the role of PHA-4 in dietary restriction, and the development of mouse models for HSF-1 activation. His lab has pioneered methodologies to analyze translational regulation and organelle communication.
Awards: Howard Hughes Medical Institute Investigator (2007–present).
Grants & Collaborations: Extensive funding from HHMI and NIH, with a focus on translational research for age-related diseases. Collaborations span stem cell biology, systems biology, and neurodegeneration studies.
Labs/Teams: The Dillin Lab at UC Berkeley is a multidisciplinary group working at the intersection of cell biology, genetics, and systems physiology. Their work aims to uncover therapeutic strategies for diseases like Alzheimer’s and metabolic disorders.
